|
CACHD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.100400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.238050E-01 |
| Normal-vs-Stage2 |
1.737210E-03 |
| Normal-vs-Stage3 |
6.762400E-03 |
| Normal-vs-Stage4 |
1.029650E-02 |
| Stage1-vs-Stage2 |
1.693930E-02 |
| Stage1-vs-Stage3 |
1.189230E-01 |
| Stage1-vs-Stage4 |
1.124170E-01 |
| Stage2-vs-Stage3 |
2.091400E-01 |
| Stage2-vs-Stage4 |
3.390800E-01 |
| Stage3-vs-Stage4 |
8.455400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.980900E-03 |
| Normal-vs-AfricanAmerican |
3.761600E-01 |
| Normal-vs-Asian |
5.111400E-01 |
| Caucasian-vs-AfricanAmerican |
7.022000E-03 |
| Caucasian-vs-Asian |
1.691390E-01 |
| AfricanAmerican-vs-Asian |
1.975820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.926100E-02 |
| Normal-vs-Female |
9.758900E-03 |
| Male-vs-Female |
6.507800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.413240E-01 |
| Normal-vs-Age(41-60Yrs) |
2.832100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.757480E-03 |
| Normal-vs-Age(81-100Yrs) |
8.071200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.717800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.900100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.360600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.269360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.419200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.467600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.662100E-03 |
| Classical-VS-Follicular |
4.541900E-02 |
| Classical-VS-Other |
6.764000E-01 |
| Classical-VS-Normal |
1.353770E-01 |
| Tall-VS-Follicular |
6.356000E-01 |
| Tall-VS-Other |
4.927200E-01 |
| Tall-VS-Normal |
1.999620E-03 |
| Follicular-VS-Other |
8.132000E-01 |
| Follicular-VS-Normal |
8.416100E-03 |
| Other-VS-Normal |
2.595400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.495400E-03 |
| Normal-vs-N1 |
1.180480E-02 |
| N0-vs-N1 |
6.672800E-01 |
|
|
